{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T16:35:08Z","timestamp":1773160508714,"version":"3.50.1"},"reference-count":47,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2017,9,22]],"date-time":"2017-09-22T00:00:00Z","timestamp":1506038400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Genome BC, Genome Canada, Genome Quebec, and Canadian Institutes of Health Research (CIHR) Partnership in Genomics and Personalized Health","award":["Large Scale Applied Research Project HIV142"],"award-info":[{"award-number":["Large Scale Applied Research Project HIV142"]}]},{"DOI":"10.13039\/100012453","name":"Providence Health Care","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100012453","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000245","name":"Michael Smith Foundation for Health Research","doi-asserted-by":"publisher","award":["Scholar Award"],"award-info":[{"award-number":["Scholar Award"]}],"id":[{"id":"10.13039\/501100000245","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["MFE-146750"],"award-info":[{"award-number":["MFE-146750"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0184848","type":"journal-article","created":{"date-parts":[[2017,9,22]],"date-time":"2017-09-22T17:34:47Z","timestamp":1506101687000},"page":"e0184848","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":7,"title":["Sociodemographic correlates of HIV drug resistance and access to drug resistance testing in British Columbia, Canada"],"prefix":"10.1371","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4347-8015","authenticated-orcid":true,"given":"Genevieve","family":"Rocheleau","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Conrado","family":"Franco-Villalobos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalia","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zabrina L.","family":"Brumme","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melanie","family":"Rusch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeannie","family":"Shoveller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chanson J.","family":"Brumme","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P. Richard","family":"Harrigan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2017,9,22]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0140-6736(08)61113-7","article-title":"Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies","volume":"372","year":"2008","journal-title":"Lancet"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1177\/135965350100600105","article-title":"Predictors of virological response in HIV-infected patients to salvage antiretroviral therapy that includes nelfinavir","volume":"6","author":"SL Walmsley","year":"2001","journal-title":"Antivir Ther"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/00002030-200101050-00010","article-title":"Multiple drug rescue therapy for HIV-infected individuals with prior virologic failure to multiple regimens","volume":"15","author":"JS Montaner","year":"2001","journal-title":"AIDS"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1097\/00002030-199910010-00008","article-title":"Baseline HIV drug resistance profile predicts response to ritonavir-saquinavir protease inhibitor therapy in a community setting","volume":"13","author":"PR Harrigan","year":"1999","journal-title":"AIDS"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1086\/315243","article-title":"Human immunodeficiency virus-infected persons with mutations conferring resistance to zidovudine show reduced virologic responses to hydroxyurea and stavudine-lamivudine","volume":"181","author":"JS Montaner","year":"2000","journal-title":"J Infect Dis"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/00002030-200001280-00012","article-title":"HIV-1 reverse transcriptase (RT) genotype and susceptibility to RT inhibitors during abacavir monotherapy and combination therapy","volume":"14","author":"V Miller","year":"2000","journal-title":"AIDS"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1097\/00002030-200103300-00009","article-title":"HIV protease and reverse transcriptase variation and therapy outcome in antiretroviral-naive individuals from a large North American cohort","volume":"15","author":"CS Alexander","year":"2001","journal-title":"AIDS"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"F83","DOI":"10.1097\/00002030-200006160-00001","article-title":"A randomized study of antiretroviral management based on plasma genotypic antiretroviral resistance testing in patients failing therapy","volume":"14","author":"JD Baxter","year":"2000","journal-title":"AIDS"},{"key":"ref9","unstructured":"National Institutes of Health (NIH). Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents Drug-Resistance Testing Genotypic and Phenotypic Resistance Assays [Internet]. 2014. <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/aidsinfo.nih.gov\/guidelines\" xlink:type=\"simple\">http:\/\/aidsinfo.nih.gov\/guidelines<\/ext-link>"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1016\/S0140-6736(98)12291-2","article-title":"Drug-resistance genotyping in HIV-1 therapy: The VIRADAPT randomised controlled trial","volume":"353","author":"J Durant","year":"1999","journal-title":"Lancet"},{"key":"ref11","unstructured":"British Columbia Centre for Excellence in HIV\/AIDS. Primary Care Guidelines for the Management of HIV\/AIDS in British Columbia on behalf of the Primary Care Guidelines Panel BC Centre for Excellence in HIV\/AIDS. 2015."},{"key":"ref12","unstructured":"DHHS Panel on Antiretroviral Guidelines for Adults and Adolescents, Office of AIDS Research Advisory Council (OARAC). Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents [Internet]. 2016. <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/aidsinfo.nih.gov\/guidelines\" xlink:type=\"simple\">http:\/\/aidsinfo.nih.gov\/guidelines<\/ext-link>"},{"key":"ref13","unstructured":"British Columbia Centre for Excellence in HIV\/AIDS. Primary Care Guidelines for the Management of HIV\/AIDS in British Columbia On behalf of the Primary Care Guidelines Panel BC Centre for Excellence in HIV\/AIDS [Internet]. 2015. <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.cfenet.ubc.ca\/sites\/default\/files\/uploads\/primary-care-guidelines\/primary-care-guidelines_015-09-15.pdf\" xlink:type=\"simple\">http:\/\/www.cfenet.ubc.ca\/sites\/default\/files\/uploads\/primary-care-guidelines\/primary-care-guidelines_015-09-15.pdf<\/ext-link>"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1089\/apc.2006.0202","article-title":"The Effect of Perceived Stigma from a Health Care Provider on Access to Care Among a Low-Income HIV-Positive Population","volume":"21","author":"JJ Kinsler","year":"2007","journal-title":"AIDS Patient Care STDS"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1089\/apc.2006.103","article-title":"Utilization of Health Care Services in Hard-to-Reach Marginalized HIV-Infected Individuals","volume":"21","author":"CO Cunningham","year":"2007","journal-title":"AIDS Patient Care STDS"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s10461-007-9246-3","article-title":"The Effects of Housing Status on Health-Related Outcomes in People living with HIV: A Systematic Review of the Literature","volume":"11","author":"CA Leaver","year":"2007","journal-title":"AIDS Behav. Springer US"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1186\/s12889-015-2197-0","article-title":"Stigma, HIV and health: a qualitative synthesis","volume":"15","author":"LA Chambers","year":"2015","journal-title":"BMC Public Health"},{"key":"ref18","article-title":"Exploring How Substance Use Impedes Engagement along the HIV Care Continuum: A Qualitative Study","volume":"4","author":"M Gwadz","year":"2016","journal-title":"Front Public Heal"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1080\/09540121.2014.986050","article-title":"Factors impacting HIV testing: a review\u2013perspectives from Australia, Canada, and the UK","volume":"27","author":"K Bolsewicz","year":"2015","journal-title":"AIDS Care. Routledge"},{"key":"ref20","first-page":"12","article-title":"Retention in HIV care: what the clinician needs to know","volume":"19","author":"TP Giordano","year":"2010","journal-title":"Top Antivir Med"},{"key":"ref21","unstructured":"Denning P, Dinenno E. Communities in crisis : Is there a generalized HIV epidemic in impoverished urban areas of the United States ? [Internet]. Center for Disease Control and Prevention. 2015. <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.cdc.gov\/hiv\/group\/poverty.html\" xlink:type=\"simple\">http:\/\/www.cdc.gov\/hiv\/group\/poverty.html<\/ext-link>"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1097\/QAI.0b013e3181648dfd","article-title":"Impact of Neighborhood-Level Socioeconomic Status on HIV Disease Progression in a Universal Health Care Setting","volume":"47","author":"R Joy","year":"2008","journal-title":"JAIDS J Acquir Immune Defic Syndr"},{"key":"ref23","article-title":"Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and Elaboration10* for the STROBE Initiative","author":"JP Vandenbroucke","year":"2007","journal-title":"Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and Elaboration10* for the STROBE Initiative"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1097\/00042560-200004010-00016","article-title":"Adherence to triple therapy and viral load response","volume":"23","author":"S Low-Beer","year":"2000","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref25","article-title":"R: A language and environment for statistical computing","year":"2008"},{"key":"ref26","unstructured":"SAS Institute Inc. SAS 9.4 Software. Cary, NC, USA; 2013."},{"key":"ref27","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1086\/427192","article-title":"Predictors of HIV drug-resistance mutations in a large antiretroviral-naive cohort initiating triple antiretroviral therapy","volume":"191","author":"PR Harrigan","year":"2005","journal-title":"J Infect Dis"},{"key":"ref28","unstructured":"Gene Codes Corperation. Sequencher<sup>\u00ae<\/sup> version 5.4.6 DNA sequence analysis software. In: Ann Arbor, MI USA [Internet]. [cited 25 Apr 2017]. <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.genecodes.com\" xlink:type=\"simple\">http:\/\/www.genecodes.com<\/ext-link>"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1128\/JCM.06689-11","article-title":"Automating HIV drug resistance genotyping with RECall, a freely accessible sequence analysis tool","volume":"50","author":"CK Woods","year":"2012","journal-title":"J Clin Microbiol"},{"key":"ref30","first-page":"6","article-title":"Update of the Drug Resistance Mutations in HIV-1: March 2013","volume":"21","author":"VA Johnson","year":"2013","journal-title":"Top Antiretrovir Med"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1080\/09540120412331291715","article-title":"Prediction of adherence to antiretroviral therapy: A one-year longitudinal study","volume":"17","author":"G Godin","year":"2005","journal-title":"AIDS Care. BioMed Central"},{"key":"ref32","first-page":"656","article-title":"Adherence and plasma HIV RNA responses to highly active antiretroviral therapy among HIV-1 infected injection drug users","volume":"169","author":"E Wood","year":"2003","journal-title":"C Can Med Assoc J"},{"key":"ref33","article-title":"Longitudinal Trends of HIV Drug Resistance in a Large Canadian Cohort; 1996\u20132016","volume":"0","author":"G Rocheleau","year":"2017","journal-title":"Clin Microbiol Infect. Elsevier"},{"key":"ref34","first-page":"656","article-title":"Adherence and plasma HIV RNA responses to highly active antiretroviral therapy among HIV-1 infected injection drug users","volume":"169","author":"E Wood","year":"2003","journal-title":"CMAJ. Association = L\u2019Association"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.drugpo.2013.11.011","article-title":"Income level and drug related harm among people who use injection drugs in a Canadian setting","volume":"25","author":"C Long","year":"2014","journal-title":"Int J Drug Policy"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1086\/427192","article-title":"Predictors of HIV drug-resistance mutations in a large antiretroviral-naive cohort initiating triple antiretroviral therapy","volume":"191","author":"PR Harrigan","year":"2005","journal-title":"J Infect Dis"},{"key":"ref37","unstructured":"Statistics Canada. 2011 Census; Aboriginal Peoples in Canada: First Nations People, M\u00e9tis and Inuit [Internet]. 2011. <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www12.statcan.gc.ca\/nhs-enm\/2011\/as-sa\/99-011-x\/99-011-x2011001-eng.cfm\" xlink:type=\"simple\">http:\/\/www12.statcan.gc.ca\/nhs-enm\/2011\/as-sa\/99-011-x\/99-011-x2011001-eng.cfm<\/ext-link>"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1097\/00002030-199909100-00021","article-title":"Sociodemographic and psychological variables influencing adherence to antiretroviral therapy","volume":"13","author":"V Gordillo","year":"1999","journal-title":"AIDS"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S1473-3099(13)70254-8","article-title":"The cascade of HIV care in British Columbia, Canada, 1996\u20132011: a population-based retrospective cohort study","volume":"14","author":"B Nosyk","year":"2014","journal-title":"Lancet Infect Dis"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1378\/chest.128.4_MeetingAbstracts.404S-a","article-title":"Evaluation of risk factors and prevalence of drug resistant tuberculosis in North India","volume":"128","author":"JN Pande","year":"2005","journal-title":"Chest"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1136\/thx.2004.026922","article-title":"Rates of drug resistance and risk factor analysis in civilian and prison patients with tuberculosis in Samara Region, Russia","volume":"60","author":"M Ruddy","year":"2005","journal-title":"Thorax"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s10096-008-0627-y","article-title":"Risk factors for multidrug-resistant tuberculosis in a tuberculosis unit in Madrid, Spain","volume":"28","author":"I Su\u00e1rez-Garc\u00eda","year":"2009","journal-title":"Eur J Clin Microbiol Infect Dis. Springer-Verlag"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1590\/S0102-35862003000200008","article-title":"Risk factors for acquired multidrug-resistant tuberculosis","volume":"29","author":"EC Barroso","year":"2003","journal-title":"J Pneumol J Pneumol"},{"key":"ref44","first-page":"158","article-title":"Risk factors for multidrug resistant tuberculosis in Europe: a systematic review","volume":"61","author":"A Faustini","year":"2006","journal-title":"Thorax. BMJ Publishing Group Ltd and British Thoracic Society"},{"key":"ref45","unstructured":"Smith WR. The 2011 National Household Survey: the complete statistical story. In: StatCan Blog [Internet]. 2015 [cited 31 Oct 2016]. <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.statcan.gc.ca\/eng\/blog-blogue\/cs-sc\/2011NHSstory\" xlink:type=\"simple\">http:\/\/www.statcan.gc.ca\/eng\/blog-blogue\/cs-sc\/2011NHSstory<\/ext-link>"},{"key":"ref46","unstructured":"British Columbia Centre for Excellence in HIV\/AIDS. Therapeutic Guidelines for the Treatment of HIV\/AIDS and Related Conditions. Vancouver; 1999."},{"key":"ref47","unstructured":"British Columbia Centre for Excellence in HIV\/AIDS. Therapeutic Guidelines Antiretroviral Therapy for HIV-1 Infected Adults. Vancouver; 2006."}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0184848","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,3]],"date-time":"2022-08-03T06:48:32Z","timestamp":1659509312000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0184848"}},"subtitle":[],"editor":[{"given":"Georgios \u039a","family":"Nikolopoulos","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2017,9,22]]},"references-count":47,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2017,9,22]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0184848","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9,22]]}}}